Fortis Healthcare Limited Share Price & Analysis
₹961.1Updated 5 Jun 2026, 03:30 pm IST
LTP
₹961.1
—
Open
₹946.5
High
₹972
Low
₹941.55
Close
₹940.65
52W High
₹1,105
52W Low
₹723
Volume
1545K
Lot Size
775
Sector
Healthcare
Market Cap
₹70K Cr
Face Value
₹10
Large CapNIFTY 200NIFTY 500MIDCAP 100
Price Chart
Fundamentals
P/E
66.3
Sector P/E
48.9
P/B
7.34
EPS
₹12.72
ROE
11.3%
ROCE
13.5%
D/E Ratio
0.35
Div Yield
0.11%
Book Value
₹131
+
Strengths
- ✓Low debt relative to equity (D/E 0.4x)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,783 | ₹4.3L Cr | 34.4 | 5.12 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹6,616 | ₹1.7L Cr | 66.1 | 10.48 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,416 | ₹1.5L Cr | 66.4 | 17.81 | 27.6 | 15.4 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,315 | ₹1.2L Cr | 59.5 | 12.62 | 22.1 | 17.9 | 0.88 |
| CIPLA Cipla Limited | ₹1,402 | ₹1.1L Cr | 27.3 | 3.29 | 12.4 | 16.6 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,091 | ₹1.1L Cr | 20 | 4.05 | 21.2 | 21.2 | 0.38 |
| DRREDDY Dr. Reddy's Laboratories Limited | ₹1,283 | ₹1.1L Cr | 25.4 | 2.83 | 11.8 | 13.6 | 0.16 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
FORTIS · as of Mar 2026
Promoters31.17%
FII27.40%▲0.63
DII29.46%▼0.59
Public11.98%▼0.04
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 31.17% | 31.17% | 31.17% | 31.17% | 31.17% | 31.17% |
| FII | 23.72% | 23.24% | 23.31% | 25.26% | 26.77% | 27.40% |
| DII | 29.42% | 31.14% | 32.31% | 30.73% | 30.05% | 29.46% |
| Public | 15.71% | 14.44% | 13.22% | 12.83% | 12.02% | 11.98% |
Corporate Events
To consider and approve the financial results for the period ended March 31, 2026 and recommendation of Final Dividend for the year ended March 31, 2026.
Dividend21 May 2026
Dividend - Re 1 Per Share
Dividend24 Jul 2025
Dividend - Re 1 Per Share
Dividend23 Jul 2024
Dividend - Re 1 Per Share
Dividend19 Jul 2023
Latest News
All news →Financials
Quarterly Results
| Metric | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹2.3K Cr ▼2.8% | ₹2.3K Cr ▲7.6% | ₹2.2K Cr ▲8.0% | ₹2.0K Cr ▲4.1% | ₹1.9K Cr ▼3.0% | ₹2.0K Cr ▲6.9% | ₹1.9K Cr ▲4.1% | ₹1.8K Cr |
| Op. Profit | ₹506 Cr ▼9.0% | ₹556 Cr ▲13.2% | ₹491 Cr ▲12.9% | ₹435 Cr ▲16.0% | ₹375 Cr ▼13.8% | ₹435 Cr ▲26.8% | ₹343 Cr ▼10.0% | ₹381 Cr |
| OPM | 22.0% ▼8.3% | 24.0% ▲4.3% | 23.0% ▲4.5% | 22.0% ▲15.8% | 19.0% ▼13.6% | 22.0% ▲22.2% | 18.0% ▼14.3% | 21.0% |
| Net Profit | ₹197 Cr ▼40.1% | ₹329 Cr ▲23.2% | ₹267 Cr ▲42.0% | ₹188 Cr ▼26.0% | ₹254 Cr ▲31.6% | ₹193 Cr ▲10.9% | ₹174 Cr ▼14.3% | ₹203 Cr |
| EPS (₹) | 2.57 ▼39.7% | 4.26 ▲23.5% | 3.45 ▲41.4% | 2.44 ▼25.6% | 3.28 ▲40.2% | 2.34 ▲6.4% | 2.2 ▼7.2% | 2.37 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹9.1K Cr ▲17.3% | ₹7.8K Cr ▲12.9% | ₹6.9K Cr ▲9.4% | ₹6.3K Cr ▲10.1% | ₹5.7K Cr ▲41.9% | ₹4.0K Cr ▼13.0% | ₹4.6K Cr ▲3.6% | ₹4.5K Cr ▼2.0% | ₹4.6K Cr ▼0.3% | ₹4.6K Cr |
| Expenses | ₹7.0K Cr ▲13.7% | ₹6.2K Cr ▲10.1% | ₹5.6K Cr ▲8.3% | ₹5.2K Cr ▲11.8% | ₹4.6K Cr ▲28.2% | ₹3.6K Cr ▼9.8% | ₹4.0K Cr ▼5.1% | ₹4.2K Cr ▼1.1% | ₹4.3K Cr ▲1.6% | ₹4.2K Cr |
| Op. Profit | ₹2.1K Cr ▲31.3% | ₹1.6K Cr ▲25.2% | ₹1.3K Cr ▲15.2% | ₹1.1K Cr ▲3.0% | ₹1.1K Cr ▲164.6% | ₹404 Cr ▼33.8% | ₹610 Cr ▲164.1% | ₹231 Cr ▼15.7% | ₹274 Cr ▼22.6% | ₹354 Cr |
| OPM | 23.0% ▲15.0% | 20.0% ▲11.1% | 18.0% ▲5.9% | 17.0% ▼10.5% | 19.0% ▲90.0% | 10.0% ▼23.1% | 13.0% ▲160.0% | 5.0% ▼16.7% | 6.0% ▼25.0% | 8.0% |
| Other Income | ₹45 Cr ▲509.1% | ₹-11 Cr ▼117.2% | ₹64 Cr ▼59.2% | ₹157 Cr ▼57.2% | ₹367 Cr ▲286.3% | ₹95 Cr ▼24.6% | ₹126 Cr ▼44.7% | ₹228 Cr ▲133.1% | ₹-689 Cr ▼206.2% | ₹649 Cr |
| Interest | ₹314 Cr ▲70.7% | ₹184 Cr ▲40.5% | ₹131 Cr ▲1.6% | ₹129 Cr ▼12.2% | ₹147 Cr ▼11.4% | ₹166 Cr ▼19.0% | ₹205 Cr ▼39.2% | ₹337 Cr ▲30.6% | ₹258 Cr ▲12.7% | ₹229 Cr |
| Depreciation | ₹449 Cr ▲16.3% | ₹386 Cr ▲12.9% | ₹342 Cr ▲8.2% | ₹316 Cr ▲5.0% | ₹301 Cr ▲3.4% | ₹291 Cr ▼0.3% | ₹292 Cr ▲25.3% | ₹233 Cr ▼2.5% | ₹239 Cr ▲7.7% | ₹222 Cr |
| PBT | ₹1.4K Cr ▲35.7% | ₹1.0K Cr ▲17.4% | ₹858 Cr ▲5.4% | ₹814 Cr ▼17.6% | ₹988 Cr ▲2197.7% | ₹43 Cr ▼82.0% | ₹239 Cr ▲317.3% | ₹-110 Cr ▲87.9% | ₹-912 Cr ▼265.2% | ₹552 Cr |
| Tax % | 22.0% ▲10.0% | 20.0% ▼20.0% | 25.0% ▲13.6% | 22.0% ▲10.0% | 20.0% ▼91.3% | 230.0% ▲271.0% | 62.0% ▼39.8% | 103.0% ▲5050.0% | 2.0% ▼84.6% | 13.0% |
| Net Profit | ₹1.1K Cr ▲31.5% | ₹809 Cr ▲25.4% | ₹645 Cr ▲1.9% | ₹633 Cr ▼19.9% | ₹790 Cr ▲1510.7% | ₹-56 Cr ▼161.5% | ₹91 Cr ▲140.6% | ₹-224 Cr ▲76.0% | ₹-934 Cr ▼295.0% | ₹479 Cr |
| EPS (₹) | 13.8 ▲34.5% | 10.26 ▲29.4% | 7.93 ▲1.7% | 7.8 ▲6.1% | 7.35 ▲606.9% | -1.45 ▼288.3% | 0.77 ▲119.4% | -3.96 ▲79.7% | -19.46 ▼339.1% | 8.14 |
| Div Payout | 7.0% ▼30.0% | 10.0% ▼23.1% | 13.0% ▲0.0% | 13.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Sep 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities | ||||||||||
| Equity Capital | ₹755 Cr ▲0.0% | ₹755 Cr ▲0.0% | ₹755 Cr ▲0.0% | ₹755 Cr ▲0.0% | ₹755 Cr ▲0.0% | ₹755 Cr ▲0.0% | ₹755 Cr ▲0.0% | ₹755 Cr ▲45.5% | ₹519 Cr ▲0.2% | ₹518 Cr |
| Reserves | ₹8.7K Cr ▲6.3% | ₹8.2K Cr ▲18.2% | ₹6.9K Cr ▲6.5% | ₹6.5K Cr ▲19.6% | ₹5.4K Cr ▲1.1% | ₹5.4K Cr ▼9.2% | ₹5.9K Cr ▲1.0% | ₹5.8K Cr ▲65.0% | ₹3.5K Cr ▼23.4% | ₹4.6K Cr |
| Borrowings | ₹3.2K Cr ▲29.1% | ₹2.5K Cr ▲114.3% | ₹1.2K Cr ▲24.7% | ₹926 Cr ▼26.2% | ₹1.3K Cr ▼18.0% | ₹1.5K Cr ▼4.0% | ₹1.6K Cr ▼20.7% | ₹2.0K Cr ▲2.4% | ₹2.0K Cr ▼11.5% | ₹2.2K Cr |
| Other Liabilities | ₹2.4K Cr ▲20.4% | ₹2.0K Cr ▼52.2% | ₹4.2K Cr ▲5.9% | ₹3.9K Cr ▼3.9% | ₹4.1K Cr ▲26.9% | ₹3.2K Cr ▲15.6% | ₹2.8K Cr ▼3.3% | ₹2.9K Cr ▲17.1% | ₹2.5K Cr ▲10.2% | ₹2.2K Cr |
| Total Liabilities | ₹15.0K Cr ▲12.2% | ₹13.4K Cr ▲3.1% | ₹13.0K Cr ▲7.3% | ₹12.1K Cr ▲5.0% | ₹11.5K Cr ▲6.0% | ₹10.9K Cr ▼1.5% | ₹11.0K Cr ▼3.9% | ₹11.5K Cr ▲35.5% | ₹8.5K Cr ▼11.6% | ₹9.6K Cr |
| Assets | ||||||||||
| Fixed Assets | ₹11.7K Cr ▲12.3% | ₹10.4K Cr ▲5.6% | ₹9.9K Cr ▲4.8% | ₹9.4K Cr ▲0.1% | ₹9.4K Cr ▲7.0% | ₹8.8K Cr ▼0.0% | ₹8.8K Cr ▲3.8% | ₹8.5K Cr ▲69.8% | ₹5.0K Cr ▼7.9% | ₹5.4K Cr |
| CWIP | ₹306 Cr ▼24.8% | ₹407 Cr ▼24.9% | ₹542 Cr ▲137.7% | ₹228 Cr ▲18.1% | ₹193 Cr ▲17.0% | ₹165 Cr ▼19.1% | ₹204 Cr ▼54.7% | ₹450 Cr ▲99.1% | ₹226 Cr ▼15.7% | ₹268 Cr |
| Investments | ₹220 Cr ▲30.2% | ₹169 Cr ▼26.5% | ₹230 Cr ▲9.5% | ₹210 Cr ▲101.9% | ₹104 Cr ▼44.1% | ₹186 Cr ▲6.3% | ₹175 Cr ▼35.2% | ₹270 Cr ▼84.4% | ₹1.7K Cr ▼7.8% | ₹1.9K Cr |
| Other Assets | ₹2.8K Cr ▲17.1% | ₹2.4K Cr ▲2.2% | ₹2.3K Cr ▲4.5% | ₹2.2K Cr ▲23.4% | ₹1.8K Cr ▲5.1% | ₹1.7K Cr ▼7.5% | ₹1.9K Cr ▼19.0% | ₹2.3K Cr ▲49.8% | ₹1.5K Cr ▼24.4% | ₹2.0K Cr |
| Total Assets | ₹15.0K Cr ▲12.2% | ₹13.4K Cr ▲3.1% | ₹13.0K Cr ▲7.3% | ₹12.1K Cr ▲5.0% | ₹11.5K Cr ▲6.0% | ₹10.9K Cr ▼1.5% | ₹11.0K Cr ▼3.9% | ₹11.5K Cr ▲35.5% | ₹8.5K Cr ▼11.6% | ₹9.6K Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating CF | ₹1.4K Cr ▲29.5% | ₹1.1K Cr ▲33.8% | ₹822 Cr ▼5.0% | ₹865 Cr ▲78.4% | ₹485 Cr ▲182.0% | ₹172 Cr ▲196.1% | ₹-179 Cr ▼136.3% | ₹493 Cr ▼49.0% | ₹966 Cr ▲395.4% | ₹195 Cr |
| Investing CF | ₹-780 Cr ▲12.3% | ₹-889 Cr ▼139.0% | ₹-372 Cr ▲25.7% | ₹-501 Cr ▼282.4% | ₹-131 Cr ▼307.9% | ₹63 Cr ▲101.9% | ₹-3.3K Cr ▼884.7% | ₹-333 Cr ▲66.7% | ₹-1.0K Cr ▼920.5% | ₹122 Cr |
| Financing CF | ₹-714 Cr ▼730.2% | ₹-86 Cr ▲81.7% | ₹-471 Cr ▲8.9% | ₹-517 Cr ▼261.5% | ₹-143 Cr ▲83.4% | ₹-862 Cr ▼120.2% | ₹4.3K Cr ▲733.5% | ₹-672 Cr ▼359.5% | ₹259 Cr ▲173.2% | ₹-354 Cr |
| Net Cash Flow | ₹-70 Cr ▼156.0% | ₹125 Cr ▲695.2% | ₹-21 Cr ▲86.3% | ₹-153 Cr ▼172.2% | ₹212 Cr ▲133.8% | ₹-627 Cr ▼178.5% | ₹799 Cr ▲255.8% | ₹-513 Cr ▼328.0% | ₹225 Cr ▲708.1% | ₹-37 Cr |
| Free Cash Flow | ₹591 Cr ▲243.6% | ₹172 Cr ▼53.1% | ₹367 Cr ▼51.1% | ₹750 Cr ▲173.7% | ₹274 Cr ▲682.9% | ₹35 Cr ▲113.4% | ₹-261 Cr ▼159.7% | ₹437 Cr ▼36.6% | ₹689 Cr ▲525.3% | ₹-162 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 37d ▲12.1% | 33d ▼2.9% | 34d ▲3.0% | 33d ▼19.5% | 41d ▲13.9% | 36d ▼18.2% | 44d ▲15.8% | 38d ▲0.0% | 38d ▼2.6% | 39d |
| Inventory Days | 23d ▼4.2% | 24d ▼22.6% | 31d ▼6.1% | 33d ▲13.8% | 29d ▼3.3% | 30d ▲36.4% | 22d ▼8.3% | 24d ▲4.3% | 23d ▲0.0% | 23d |
| Days Payable | 161d ▼1.8% | 164d ▼8.4% | 179d ▲0.6% | 178d ▼13.2% | 205d ▼9.3% | 226d ▼23.6% | 296d ▲6.1% | 279d ▲29.8% | 215d ▼1.4% | 218d |
| Cash Conv. Cycle | -101d ▲5.6% | -107d ▲7.0% | -115d ▼2.7% | -112d ▲17.0% | -135d ▲16.1% | -161d ▲30.0% | -230d ▼6.0% | -217d ▼40.0% | -155d ▲0.6% | -156d |
| Working Capital Days | -30d ▲75.8% | -124d ▼463.6% | -22d ▲37.1% | -35d ▲37.5% | -56d ▲62.7% | -150d ▲35.9% | -234d ▼107.1% | -113d ▼29.9% | -87d ▼26.1% | -69d |
| ROCE | 12.0% ▲20.0% | 10.0% ▲0.0% | 10.0% ▲0.0% | 10.0% ▲400.0% | 2.0% ▼50.0% | 4.0% ▼33.3% | 6.0% ▲100.0% | 3.0% ▼72.7% | 11.0% ▲266.7% | 3.0% |
Source: Screener.in · Lower days = better efficiency
Deep Dive Analysis
About Fortis Healthcare Limited
FHL was incorporated in February 1996. The company’s first healthcare facility became operational in Mohali, Punjab in 2001. It is a leading integrated healthcare service provider in India. The healthcare verticals of the company primarily comprise hospitals, diagnostics and day care specialty facilities. Currently, the company operates its healthcare delivery services in India, Nepal, Dubai and Sri Lanka with 36 healthcare facilities with approximately 4,000 operational beds. [1]
Healthcare · Healthcare Services
Related Analysis
Frequently Asked Questions
What is Fortis Healthcare Limited share price today?▾
Fortis Healthcare Limited (FORTIS) is currently trading at ₹961.1 on NSE, as of the last market session. Prices update daily after market close on MarketNetra.
Is Fortis Healthcare Limited available in F&O (Futures & Options)?▾
Yes, Fortis Healthcare Limited (FORTIS) is part of the NSE F&O segment with a lot size of 775 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Fortis Healthcare Limited 52-week high and low?▾
Fortis Healthcare Limited's 52-week high is ₹1,105 and the 52-week low is ₹723. The current price of ₹961.1 is 13.0% below the 52W high.
What is Fortis Healthcare Limited P/E ratio?▾
Fortis Healthcare Limited's current P/E ratio is 66.3. This indicates the market is paying ₹66.3 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Fortis Healthcare Limited options?▾
Fortis Healthcare Limited options are traded on NSE with monthly expiry contracts (lot size: 775 shares). To trade FORTIS options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.